CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...